Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
D000700:Analgesics / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D000932:Antiemetics / Q000494:pharmacology; D000996:Antitussive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D003061:Codeine / Q000494:pharmacology; D003248:Constipation / Q000139:chemically induced; D003864:Depression, Chemical; D004285:Dogs; D004357:Drug Synergism; D004569:Electroencephalography; D005021:Ethylamines / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006591:Hexobarbital / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007422:Intestines / Q000187:drug effects; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009184:Mydriatics / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects*; D013268:Stimulation, Chemical; D014203:Tremorine / Q000037:antagonists & inhibitors
D000700:Analgesics; D000779:Anesthetics, Local; D000927:Anticonvulsants; D000932:Antiemetics; D000996:Antitussive Agents; D005021:Ethylamines; D006634:Histamine H1 Antagonists; D009184:Mydriatics; D006591:Hexobarbital; D014203:Tremorine; D003061:Codeine